文献速递肿瘤 PET/CT甲状腺核医学

18F-氟胆碱PET/MRI与18F-氟胆碱PET/CT作为原发性甲状旁腺功能亢进症一线及二线影像学检查——谁领风骚?

[18F]Fluorocholine PET/MRI and [18F]Fluorocholine PET/CT as first- and second-line imaging in primary hyperparathyroidism - who takes the lead?
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-05-30

该回顾性研究评估了18F-氟胆碱PET/MRI与PET/CT作为一线及二线方法定位甲状旁腺腺瘤的诊断准确性,以术中定位及组织病理学为金标准。共纳入322例患者,两种方法在总体及一线、二线场景下的灵敏度、特异度、阳性预测值、阴性预测值及诊断准确性均无显著差异(均P>0.05)。作者认为两者均为高精度影像技术,可作为术前评估的顶级或一站式技术。

要点

  • 18F-氟胆碱PET/MRI与PET/CT定位甲状旁腺腺瘤的总体诊断性能均很高,各参数间均P>0.05。
  • 一线与二线场景下,两种方法的诊断性能均无显著差异。
  • 作者认为两者可作为术前评估的顶级或一站式技术。

核心结论

  • 18F-氟胆碱PET/MRI与PET/CT在一线和二线场景下均为定位甲状旁腺腺瘤的高精度影像方法。
  • 作者认为两者可被视为术前评估的顶级或一站式技术。

研究设计与样本

  • 回顾性研究,评估18F-氟胆碱PET/MRI与PET/CT作为一线和二线方法检测原发性甲状旁腺功能亢进症患者甲状旁腺腺瘤的诊断准确性。
  • 共纳入322例患者;264例接受18F-氟胆碱PET/MRI,其中155例为二线、109例为一线;58例接受18F-氟胆碱PET/CT,其中44例为二线、14例为一线。
  • 以术中手术定位和组织病理学分析为参考标准(金标准)。
  • 主要终点为基于患者的灵敏度、特异度、阳性预测值。

主要发现

  • 18F-氟胆碱PET/MRI的总体灵敏度、特异度、阳性预测值、阴性预测值及诊断准确性分别为0.967、0.818、0.983、0.692和0.955。
  • 18F-氟胆碱PET/CT的总体灵敏度、特异度、阳性预测值、阴性预测值及诊断准确性分别为0.980、0.875、0.980、0.875和0.966。
  • 两种方法间上述参数比较均P>0.05。
  • 在一线或二线影像场景下,两种方法间亦无差异。

关键数值与推荐

  • 18F-氟胆碱PET/MRI总体灵敏度0.967、特异度0.818、阳性预测值0.983、阴性预测值0.692、诊断准确性0.955。
  • 18F-氟胆碱PET/CT总体灵敏度0.980、特异度0.875、阳性预测值0.980、阴性预测值0.875、诊断准确性0.966。
  • 两种方法各参数比较均P>0.05。
  • 一线及二线场景下两种方法间无差异。

临床怎么用

  • 作者认为18F-氟胆碱PET/MRI与PET/CT可视为术前评估的顶级或一站式技术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Accurate preoperative localization of hyperfunctioning parathyroid glands is essential for enabling a focused surgical approach in patients with primary hyperparathyroidism (pHPT). Our study aims to determine the diagnostic value of 18F-fluorocholine positron emission tomography/magnetic resonance imaging ([18F]FCH PET/MRI) and [18F]FCH PET/computed tomography (PET/CT) in identifying parathyroid adenomas. METHODS: We conducted a retrospective study to assess the diagnostic accuracy of [18F]FCH PET/MRI and [18F]FCH PET/CT as first- and second-line methods for detecting parathyroid adenomas in patients with pHPT. The primary endpoints included patient-based sensitivity, specificity, and positive predictive value (PPV), with intraoperative surgical localization and histopathological analysis serving as reference, i.e., gold standard. RESULTS: The study included 322 patients. A total of 264 patients underwent [18F]FCH PET/MRI, thereof 155 and 109 as a second- and first-line method, respectively. [18F]FCH PET/CT was performed in 58 patients, thereof 44 and 14 in a second- and first-line setting, respectively. Total sensitivity, specificity, PPV, negative predictive value (NPV), and diagnostic accuracy of [18F]FCH PET/MRI were 0.967, 0.818, 0.983, 0.692, and 0.955, respectively, while the same parameters for [18F]FCH PET/CT were 0.980, 0.875, 0.980, 0.875, and 0.966, respectively (all p > 0.05). There was also no difference between the two methods in the first- or second-line imaging scenarios. CONCLUSION: Both [18F]FCH PET/MRI and [18F]FCH PET/CT are highly accurate imaging modalities for localizing parathyroid adenomas in both first- and second-line settings. They can be regarded as “top-scoring” or “one-stop-shop” techniques for preoperative assessment.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Petranović Ovčariček P, Schaab J, Beintner-Skawran S, et al. [18F]Fluorocholine PET/MRI and [18F]Fluorocholine PET/CT as first- and second-line imaging in primary hyperparathyroidism - who takes the lead? Eur J Nucl Med Mol Imaging. 2025. PMID: 40445316. doi:10.1007/s00259-025-07373-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。